Skip to main content

Il Young Choi

Hanyang University · 医学

研究室紹介

Professor Il Young Choi's research lab specializes in hematological malignancies and molecular oncology, with a focus on the pathogenesis and treatment of blood cancers such as multiple myeloma, peripheral T-cell lymphoma, and colorectal cancer. The lab investigates key biological mechanisms including angiogenesis, telomerase activation, and drug response biomarkers (e.g., thymidylate synthase, p53) to improve prognostic prediction and therapeutic strategies. Their work also explores rare paraneoplastic syndromes like eosinophilic fasciitis in association with lymphoma, highlighting translational research bridging clinical hematology and molecular pathology. The lab emphasizes the integration of molecular diagnostics with clinical outcomes to optimize personalized cancer therapy.

multiple myelomacolorectal cancertelomeraselymphomaangiogenesis

Research Overview

Papers
29
Total Citations
202
Papers (5y)
18
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
18total
2002
2003
2004
2005
2017
Citations per year (5y)
131total
20022003200420052017

Selected Papers

15
1
Article|51 citations·2005
Clinical Aspects of Pregnancy and Delivery in Patients with Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Young‐Woong Won, Won Moon, Yeong-Seop Yun, Ho-Suk Oh, Jung‐Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung‐Ju Ahn
SJR Q2The Korean Journal of Internal MedicineOA

BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) is a condition that often develops in young women and, consequently, physicians should frequently manage and monitor pregnant patients with this disorder. METHODS: We reviewed the charts of 30 women with chronic ITP delivered in 31 pregnancies from January 1995 to December 2003. RESULTS: Fifteen patients were diagnosed with ITP before pregnancy and sixteen patients were diagnosed during pregnancy. The mean platelet counts before pregnancy, du

HematologyMedicine
2
Article|38 citations·2000
Eosinophilic fasciitis preceding relapse of peripheral T-cell lymphoma
Hawk Kim, Mi‐Ok Kim, Myung‐Ju Ahn, Young Yeol Lee, Tae June Jung, Il Young Choi, In Soon Kim, Chan Kum Park
SJR Q2Journal of Korean Medical ScienceOA

Although eosinophilic fasciitis (EF) may precede hematologic malignancy or Hodgkin's disease, association with peripheral T-cell lymphoma (PTCL) is extremely rare. Only four cases of EF preceding or concomitant PTCL have been reported in the world literature. We experienced the first Korean case of EF complicated by the later relapse of peripheral T-cell lymphoma. A 63-year-old Korean male has been followed at our outpatient clinic periodically after treatment for stage IV PTCL. He had been in c

RheumatologyMedicine
3
Article|31 citations·2003
Outcome of Adult Severe or Very Severe Aplastic Anemia Treated with Immunosuppressive Therapy Compared with Bone Marrow Transplantation: Multicenter Trial
Myung‐Ju Ahn, Jung‐Hye Choi, Young-Yeul Lee, Il-Young Choi, In-Soon Kim, Sung‐Soo Yoon, Sun-Yang Park, Byung-Kook Kim, Cheolwon Suh, Hee Jeong Son, Cheol-Won Jung, Jae Hoon Lee
SJR Q2International Journal of Hematology
HematologyMedicine
4
Article|20 citations·2001
Clinical significance of microvessel density in multiple myeloma patients
Myung‐Ju Ahn, Chan Kum Park, Jung Hye Choi, Won Mee Lee, Young Yeul Lee, Il Young Choi, In Soon Kim, Woong Soo Lee, Moran Ki
SJR Q2Journal of Korean Medical ScienceOA

To investigate the role of angiogenesis in multiple myeloma (MM), bone marrow biopsy from 75 adults with newly diagnosed, untreated MM were evaluated. Microvessels were scored in at least 3 areas ( x 200 fields) of the highest microvessel density in representative sections of each bone marrow specimen using immunohistochemistry for CD34. Prognostic variables were also evaluated for the overall survival. Microvessel counts were significantly higher in patients with MM (n=69.42+/-9.67), compared w

HematologyMedicine
5
Article|17 citations·2002
Absence of Clinical Prognostic Value of Vascular Endothelial Growth Factor and Microvessel Density in Multiple Myeloma
Jung‐Hye Choi, Myung‐Ju Ahn, Se Jin Jang, Chan-Kum Park, Yong-Wook Park, Ho-Suk Oh, Young-Yuel Lee, Il-Young Choi, In-Soon Kim
SJR Q2International Journal of Hematology
HematologyMedicine
6
Article|8 citations·2004
Phase II Study of Irinotecan, 5-Fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as First-line Therapy
Young‐Woong Won, Young‐Hyo Lim, Ho-Yong Park, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung‐Ju Ahn
SJR Q1Cancer Research and TreatmentOA

BACKGROUND: The purpose of this study was to assess the efficacy and toxicity of biweekly irinotecan plus 5-fluorouracil (FU) and leucovorin (LV) in patients with relapsed or metastatic colorectal cancer. MATERIALS AND METHODS: Between March 2002 and May 2004, 24 patients with histologically confirmed relapsed or metastatic colorectal cancer were enrolled in this study. One chemotherapy cycle consisted of irinotecan 180 mg/m(2) on days 1 and 15; 5-FU 400 mg/m(2) bolus IV with 600 mg/m(2) by a 22

OncologyMedicine
7
Article|5 citations·1997
Telomerase activity in benign and malignant human thyroid nodules
Myung‐Ju Ahn, Kyung Tae, Yong Soo Park, In-Soon Kim, Il-Young Choi, Hyung‐Seok Lee, Sun-Kon Kim, Yong-Sung Lee
SJR Q1Experimental & Molecular MedicineOA

Telomerase is a ribonucleoprotein polymerase which contains an integral RNA and synthesizes TTAGGG nucleotide repeats at the ends of chromosomes in vertebrates. Accumulated evidence has indicated that telomerase is stringently repressed in normal human somatic tissues but reactivated in immortal and cancer cells, suggesting that activation of telomerase may play an important role in carcinogenesis. In order to assess the role of telomerase in the development of thyroid cancer, we measured the te

PhysiologyMedicine
8
Article|5 citations·2005
Thymidylate Synthase, Thymidine Phosphorylase, VEGF and p53 Protein Expression in Primary Colorectal Cancer for Predicting Response to 5-fluorouracil-based Chemotherapy
Myung‐Ju Ahn, Jung-Hye Choi, Ho-Suk Oh, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Kang-Hong Lee, Kang-Won Song, Chan-Kum Park
SJR Q1Cancer Research and TreatmentOA

PURPOSE: In the treatment of advanced metastatic colorectal cancer, several new agents, such as irinotecan and oxaliplatin, have been developed, which have improved both disease free and overall survivals. Among these agents, 5-fluorouracil (5-FU) still remains one of the most active agents, and the selection of patients who can benefit from 5-FU-based chemotherapy is still important, as those unlikely to benefit could be spared the harmful side effects. The expression levels of thymidylate synt

OncologyMedicine
9
Article|5 citations·2004
Radiofrequency Ablation for Metastatic Hepatic Tumor in Colorectal Carcinoma
Jung-Hye Choi, Myung‐Ju Ahn, Hyunchul Rhim, Heung Woo Lee, Ho-Suk Oh, Young-Yeul Lee, Il-Young Choi, In-Soon Kim
SJR Q1Cancer Research and TreatmentOA

PURPOSE: The purpose of this study was to assess the efficacy and safety of radiofrequency ablation (RFA) to treat hepatic metastasis in patients with colorectal carcinoma. MATERIALS AND METHODS: Between May 1999 and July 2002, a total of 45 tumors in 24 patients with colorectal cancer were treated with RFA. Thirteen patients received systemic chemotherapy after the RFA procedure. The ablation was performed percutaneously under ultrasound guidance using cool-tip or expandable electrodes and an R

HepatologyMedicine
10
Article|4 citations·2001
Clinical Prognostic Factors and Treatment Outcome of Aggressive Non-Hodgkin's Lymphoma in Elderly Patients
Jung Hye Choi, Myung‐Ju Ahn, Moran Ki, Ho Suk Oh, Young Yuel Lee, Il Young Choi, In Soon Kim
SJR Q1Cancer Research and TreatmentOA

In our experience, even elderly patients (>or=60 years) with aggressive NHL can be successfully treated with conventional chemotherapy and the important prognostic factors for survival are age, IPI, initial WBC, and CR on first line treatment.

Pathology and Forensic MedicineMedicine
11
Article|4 citations·2004
A case of posttransplantation lymphoproliferative disease developed in renal transplant recipient and treated with rituximab.
Ui Soon Park, Chan Bum Choi, In Soon Kim, Il Young Choi, Jong Myung Kang, Chan Kum Park, Myung‐Ju Ahn
SJR Q2The Korean Journal of Internal MedicineOA

Posttransplant lymphoproliferative disorder (PTLD) are among the most serious and potentially fatal complications of chronic immunosuppression in organ transplant recipient and also the most common malignancies, accounting for 21 percent of all malignancies in organ transplants versus 5 percent of malignancies in the general population. PTLD is associated with immunosuppression and Epstein Barr virus (EBV). Treatment modality of PTLD includes antiviral agent, interferon, intensive chemotherapy a

OncologyMedicine
12
Article|4 citations·2004
Rituximab으로 치료한 신이식 환자에서 발생한 이식 후 림프구 증식성 질환 1예
박의순, 최찬범, 김인순, 최일영, 강종명, 박찬금, 안명주

PTLD는 장기이식 환자에서 발생하는 치명적인 만성합병증으로 면역억제 감량, 항바이러스 제제, 화학요법, 인터페론 알파, 외과적 절제, 방사선 조사, B 세포에 대한 항체 등이 치료법으로 제시되고 있다. 저자들은 신이식 후 간 및 이식신에 발생한 미만성 거대 B세포 림프종을 진단하고 rituximab을 단독으로 사용하여 호전된 예를 경험하였기에 보고하는 바이다.

13
Article|3 citations·2000
A Case of Primary Intestinal T - Cell Lymphoma Involving Entire Gastrointestinal Tract : Esophagus to Rectum
Myung‐Ju Ahn, Yong Wook Park, Dong Soo Han, Jung Hae Choi, Sung June Shin, Byung Chul Yoon, Ho Soon Choi, Young Yeul Lee, Tae June Jung, Il Young Choi, Moon Hyang Park, In Soon Kim
SJR Q2The Korean Journal of Internal MedicineOA

Primary intestinal T-cell lymphoma is a rare disease entity, which is approximately 10% to 25% of intestinal lymphomas, and most of the lymphomas occur in the small intestine. We report here a case of a 56-year-old woman who has been suffering from chronic diarrhea and weight loss for 6 months. Abdominal CT scan and small bowel series showed diffuse wall thickening of the small bowel. Gastroscopic examination showed diffuse erythematous lesions on the esophagus and small gastric ulcerations on t

Pathology and Forensic MedicineMedicine
14
Article|2 citations·2004
Combination Chemotherapy of Heptaplatin, Paclitaxel and 5-Fluorouracil in Patients with Advanced Gastric Cancer: a Pilot Study
Myung-Ju Ahn, Ho-Suck Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Oh Young Lee, Ho-Soon Choi, Sung-Joon Kwon
SJR Q1Cancer Research and TreatmentOA

PURPOSE: To evaluate the efficacy and toxicity of heptaplatin, paclitaxel, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer. MATERIALS AND METHODS: Between July 2002 and September 2003, nineteen patients were enrolled in this study. Paclitaxel 135 mg/m(2) iv on day 1, heptaplatin 400 mg/m(2) iv on day 2 and 5-fluorouracil 800 mg/m(2) on day 2 approximately 4 were administered and the regimen was repeated every 3 weeks. RESULTS: The median age of the patients w

Pulmonary and Respiratory MedicineMedicine
15
Article|2 citations·2003
Combination Chemotherapy of Oxaliplatin and Capecitabine in Patients with Metastatic Colorectal Cancer: a Pilot Study
Myung‐Ju Ahn, Ho Suck Oh, Jung Hye Choi, Young Yeul Lee, In Soon Kim, Il Young Choi, Oh Young Lee, Heung Woo Lee
SJR Q1Cancer Research and TreatmentOA

Oxaliplatin and oral capecitabine combination chemotherapy showed significant activity and favorable toxicity in patients with metastatic colorectal cancer. Further studies, with larger numbers of patients and long-tern follow-up will be needed.

OncologyMedicine

Research Areas

OncologyHematologySurgeryPathology and Forensic MedicinePulmonary and Respiratory MedicineRheumatology

Il Young Choiの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。